Indoco Remedies Limited has informed the Exchange regarding a press release dated March 09, 2021, titled "INDOCO ANNOUNCES THE LAUNCH OF BRINZOLAMIDE OPHTHALMIC SUSPENSION 1% IN THE US MARKET BY TEVA PHARMACEUTICALS".
Indoco Remedies Limited has informed the Exchange regarding a press release dated March 09, 2021, titled "INDOCO ANNOUNCES THE LAUNCH OF BRINZOLAMIDE OPHTHALMIC SUSPENSION 1% IN THE US MARKET BY TEVA PHARMACEUTICALS".